Cara Therapeutics (LTS:0HTC) Total Liabilities : $50.62 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cara Therapeutics Total Liabilities?

Cara Therapeutics's Total Liabilities for the quarter that ended in Sep. 2024 was $50.62 Mil.

Cara Therapeutics's quarterly Total Liabilities increased from Mar. 2024 ($60.30 Mil) to Jun. 2024 ($60.90 Mil) but then declined from Jun. 2024 ($60.90 Mil) to Sep. 2024 ($50.62 Mil).

Cara Therapeutics's annual Total Liabilities increased from Dec. 2021 ($19.53 Mil) to Dec. 2022 ($23.46 Mil) and increased from Dec. 2022 ($23.46 Mil) to Dec. 2023 ($68.76 Mil).

Cara Therapeutics Total Liabilities Historical Data

The historical data trend for Cara Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics Total Liabilities Chart

Cara Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

46.25

22.16

19.53

23.46

68.76

Cara Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															29.70	68.76	60.30	60.90	50.62

Cara Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cara Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	25.592	+	(6.088	+	37.079
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	68.76

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	125.844	-	57.085
	=	68.76

Cara Therapeutics's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.039	+	(0	+	40.583
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	50.62

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	51.329	-	0.707
	=	50.62

Cara Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cara Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cara Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cara Therapeutics Inc (LTS:0HTC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CARA:USA 69C:Germany

Address

400 Atlantic Street, Suite 500, Stamford, CT, USA, 06901

Website

https://www.caratherapeutics.com

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Cara Therapeutics Headlines

No Headlines